Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Adaptimmune Therapeutics Plc ADR’s current trading price is -81.29% away from its 52-week high, while its distance from the 52-week low is 41.93%. The stock’s price range over this period has fluctuated between $0.20 and $1.48. The company, operating within the financial sector, had a trading volume of approximately 16.82 million for the day, which was noticeably higher than the average daily share volume of 1.7 million over the last 3 months.
Adaptimmune Therapeutics Plc ADR experienced a rather shaky stock market performance. The highest value in the past year was recorded at $1.48 on 07/30/24 and the lowest value was $0.20 on 04/01/25.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Adaptimmune Therapeutics Plc ADR (ADAP) has experienced a quarterly decline of -51.93% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 70.87M and boasts a workforce of 506 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.4489, with a change in price of -0.3201. Similarly, Adaptimmune Therapeutics Plc ADR recorded 1,813,788 in trading volume during the last 100 days, posting a change of -54.13%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for ADAP stands at 6.26. Similarly, the long-term debt-to-equity ratio is also 5.86.
ADAP Stock Stochastic Average
Today, Adaptimmune Therapeutics Plc ADR’s raw stochastic average for the past 50 days stands at 23.27%, indicating a decline from the raw stochastic average of the last 20 days, which was 44.12%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 64.57% and 74.79% respectively.
ADAP Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. The metric has seen a significant loss of -48.60% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -64.36%. Over the past 30 days, the price of ADAP has fallen by 24.56%. And in the last five days, it has fallen by -7.70%.
